A.         Personal Information:

Business Address:
University of Southern California School of Medicine
TRC/USC Kidney Center
2310 Alcazar St.
Los Angeles, CA 90033

Business Telephone:
(323) 441-9966

Citizenship:
USA

B.        Education:

1. High School:
Govt.  High School  # 1
Abbott Abad, Hazara, N.W.F.P.   In 1959

2. College:
F.SC (Pre-Medical) from Islamia College,
University of Peshawar, Pakistan, 1962

3. Medical College:
Khyber Medical College,
University of Peshawar, Pakistan, 1967

4. Internship:
House Physician in Internal Medicine,
Khyber Teaching Hospital, Peshawar,
9/1/1967-8/31/1968

5. Job Experience:

Pakistan Tobacco Company (British Company)
9/1/1968-1/1/1969

6. Residencies:

House Officer in General Surgery,
Orthopedics and Emergency Medicine,
Hospitals in England
2/1969-1/1970

Senior House officer, Internal Medicine and Nephrology,
Derby City Hospital, England
1/1970-5/1971

MRCP Course and House Job,
Whittington and Putney Hospital, London, England
1/1970-5/1970

Senior House Officer in Neurology,
Derbyshire Royal Infirmary, England
5/1972-1/1973

Medical Registrar in Internal Medicine
Southend General Hospitals, Essex, England
1/1973-6/1975

6. Fellowships:

Nephrology, The Christ Hospital,
Cincinnati, Ohio
7/1975-7/1977

Advanced Fellowship in Nephrology,
Los Angeles County- USC Med Center
7/1977-7/1978

7. Licensure:

California State

State of Maryland

British Medical Council

Pakistan Medical Council

C.  Academic Background:

Professor of Medicine
University of Southern California
7/1993—Present

Associate Professor of Medicine
University of Southern California
7/1985- 7/1993

Assistant Professor of Medicine
University of Southern California
7/1981-7/1985

Instructor in Internal Medicine
University of Southern California
7/1978-7/1981

Attending Physician
Los Angeles County-USC Med Center
7/1978—Present

Attending Physician
Norris Cancer Center
Since 1985

Attending Physician
USC University Hospital
Since 1990

D.        Administrative Positions:

Director, DaVita/USC Kidney Center
Department of Medicine
Univ. of  Southern California
1/1/1997 –Present

Director, USC Outpatient Dialysis
Center, Division of Nephrology
9/1989—1/97

Director, Research Laboratories
Division of Nephrology
University of Southern California
5/1983- 9/1989

Director, Renal Clinics
Division of Nephrology,
Los Angeles County-USC Med Center
7/1985- 9 /1987

E.        Committee Membership:

Member, Ethics Committee
USC University Hospital,
Los Angeles, CA

Member, Pharmacy and therapeutic committee
USC University Hospital
Los Angeles, CA

Chairman, Internal Review Committee
Division of Dermatology
LAC-USC Medical center, December, 1999

Utilization Committee
LAC-USC MED Center
7/1987-7/1994

Advisory Committee for Private Practice
Department of medicine
LAC-USC MED Center
7/1985-77/1987

Professional Services Committee
Department of Medicine
LAC-USC Med Center
7/1987-7/1997

Quality Improvement Committee
Department of Medicine
LAC-USC Med Center
7/1993–Present

Operation and Services Subcommittee
Private Practice and Growth
Department of Medicine
LAC-USC Med Center
7/1997–2002

Member, IRB
Los Angeles County-USC Med Cent
Los Angeles, CA
Since July 1996

F.         Teaching Experience:

Interns and Allied Health Professionals
Derby City and Derbyshire Royal Infirmary
England
1/1971-1/1973

Interns and Residents
Southend General Hospitals Group
Essex, England
1/1973-6/1975

Medical Students, House Staff and Renal Fellows,
LAC-USC MED Center
7/1979–Present

Medical Students’ Ward
Instructor/Preceptor
LAC-USC MED Center
7/1977-1993

Student/Resident Seminar
LAC-USC MED Center
7/1977–present

Attending Physician
Medicine, Nephrology (Ward and Consults)
LAC-USC MED Center
7/1978–Present

Mechanism of Diseases (Annual)
Nephrology Section for 2nd Year Medical Students,
University of Southern California
1981-present

Internal Medicine Review Course
Four Different Years
Since 1981

Morning Report for Medical Residents
Since July, 1998

G.        Membership of Scientific Societies:

National  Kidney Foundation

National Kidney Foundation of Southern California

American Heart (Renal Section)

Society for Advancement of Science

Association of Pakistani Physicians of North America

American Society of Nephrology

International Society of Nephrology

H.        Awards and Honors:

Awards:

Dr. Pepper Award, 2/3/2008
DaVita  Inc.
(Wild West Division)

Certificate of Excellence, 12/2007
DaVita/USC Kidney Cemter,
Wild West Division, DaVita, Inc.

APPNA Award (Service to Communiy in Medicine), 2007
By APPNA (Association of Pakistani Physicians of North America) Western Chapter

Medical Student Appreciation Certificate
Keck School of Medicine, 2007

DaVita Core Values Excellence Award, 12/2006
(DaVita/USC Kidney Center)

Certificate of Recognition, 2004-2005
(Introduction to Clinical Medicine)

Department of Family Medicine
Keck School of Medicine, USC

II year Medical Students Appreciation Certificate, 2003
(Introduction to Clinical Medicine)
Keck School of Medicine, USC

II year Medical Students Appreciation Certificate, Year 2002
(Introduction to Clinical Medicine)
Keck School of Medicine, USC

II year Medical Students Appreciation Certificate, Year 2001
(Introduction to Clinical Medicine)
Keck School of Medicine, USC

Volunteer Award, 2000
(Notable Achievement & Excellence)

At The Kidney Run/Walk
Lake Sherwood, Westlake Village, CA
(By National kidney Foundation of Southern California)

Spirit of  Nephrology Award, 6/8/ 2000
(Annual Award given to outstanding nephrologists)
National Kidney Foundation of Southern California

Outstanding Teacher
Year 11 Medical Students
Class Of 2000
Keck School of Medicine
Univ. of Southern California

Certificate of Recognition and Appreciation
(For Official Participation in DOPPS Study
1996-2000)

Falcon Award
Outstanding Contributions to Pakistani-American Community
at Los Angeles, CA
March 23, 1999

Leadership Award
Chairman of Board (1997-1999)
NKF of Southern California
June 24, 1999

Fellows Appreciation Award, 1999
Renal Fellows, Division of Nephrology
University of Southern California

Service Award, 1998
Association of Pakistani Physicians
of North America at Los Angeles, CA

Dedicated Member Award, 1998
(Organizing Committee )
19th APPNA Winter Conference
Peshawar, Pakistan

Chairman, Scientific Committee, 1998
19th APPNA Winter Conference
Khyber Medical College,
Peshawar, Pakistan

Speaker Award, 1998
International Scientific Conference
Rawalpindi Medical College
Peshawar, Pakistan

Volunteer Services Award, 1996
National kidney Foundation of Southern California

National Philanthropy Award, 1996
Los Angeles, Ca

Outstanding Effort for Annual Tribute Dinner, 1994
National Foundation of Southern California

Meritorial Services as a Board Member,
1993
(NKF of Southern California)

Honors:

Man of The year,
In Medicine and Healthcare, 2008
American Biographical Institute

America’s Top Physicians, 2008
Consumer Research Council of America

Super Doctor (Southern California), 2008
Key professional Media, Inc

Professional of The Year, 2007
The Global Directory of Who’s Who

Strathmore
Who’s Who, 2006-2007

Life Membership, 2007
Strathmore

America’s Registry of Outstanding Professionals,
2007-2008

America’s Registry of Outstanding Professionals,
2008-
Lifetime  Member

The Global Directory of Who’s Who
Life Time member, 2007—

Certificate of Membership, 2004
American Diabetes Association

President, Immediate Past
Southern California Renal Disease Council, Inc.
Network # 18,
1/2002-1/2004

President, Board of Directors,
Southern California Renal Disease Council, Inc.
ESRD Network 18,
1/2000-12002

President Elect, Board of Directors
Southern California Renal Disease Council, Inc
ESRD Network # 18,
1998-2000

Immediate Past Chairman,
Board of Directors, National Kidney Foundation of Southern California
7/1/1999-7/1/2001

Chairman, Board of Directors
National Kidney Foundation of Southern California
7/1/1997-7/1/1999

Interim Chairman, Board of Directors
National Kidney Foundation of Southern California
1/1/1997-7/1/1997

Chairman,
Patient’s Services Committee
7/1/99 -2001

President,
Medical Advisory Board
NKFSC, 7/1994-7/1996

President Elect,
Medical Advisory Board
NKFSC, 7/1992-7/1994

Vice President, khyber Alumni Association
Association of Pakistani Physicians of North America,
6/1999-6/2000

Board Member, 1997-2005
Southern California Renal Disease Council

Chairman, Nominating Committee
NKFSC Medical Advisory Board
7/1994–1998

Member Host Committee, 1998
19th Summer Scientific Committee
Association of Pakistani physicians (APPNA)
Los Angeles

Member Organizing Committee, 1998
19th Winter International Scientific Conference
APPNA, Peshawar, Pakistan

Chairman, Scientific Program, 1998
19th Winter International Scientific Conference
APPNA, Peshawar, Pakistan

Board Member, 1997-2005
Southern California Renal Dialysis Council
Network # 18

Committee Member, 1997
Annual Tribute Dinner
National Kidney Foundation of Southern California

Chairman, Budget Committee, 7/94-7/96
NKFSC Medical Advisory Board

Co-Chairman:  Host Committee
Clinical Nephrology Spring Meetings
NKF, 1996

Co-Chairman:  Host Committee
Clinical Nephrology Spring Meetings
NKF, 1996

Medical Faculty Assembly Representative
Department of Medicine
7/1/1996-7/1/1998

Co-Chairman:  Host Committee
Clinical Nephrology Spring Meetings
NKF, 1996

Board Member Center, 1996-1997
Poison Center
LAC-USC Center
Los Angeles, CA

Chairman,
Annual tribute Dinner
NKFSC, 1995

Chairman,
Annual tribute Dinner
NKFSC, 1994

Board Member, NKFSC
1994-2005

Delegate Trustee, NKFSC
1994-2001

Board Member, NKFSC
1989-1993

Committee Member, Annual Tribute Dinner
NKFSC, 1992

Member Research Committee
NKFSC, 1990, 1991

Member Compliance Committee, MDRD
NIH Study, 1989-1993

Member Fellowship Study Section
American Heart Association, 1989-1991

Member Fellowship Study Section
National Kidney Foundation, 1989-1991

Member, MFA Task Force on evaluation of Administrators,
University of Southern California, 1990

Chairman, 1987
Symposium Planning Committee
28th Annual Scientific Symposium of Kidney Diseases,
NKFSC

Vice Chairman, 1996
Symposium planning Committee
27th Annual Scientific Symposium of Kidney Diseases,
NKFSC

Secretary, 19871-989
Khyber Alumni Association
APPNA

Member Nominating Committee
NKFSC, 1987-1989

Secretary for Doctors Affairs
Southend General Hospitals group
1973-1975

President, Doctors Affairs
Derby City Hospital, England
1971-1973

I.  Research Funding:

Co-Investigator:

Parathyroid Hormone and Uremia
7/10/81-6/30/86
$619,216

Parathyroid Hormone and Uremia
7/1/86-6/30/91
$632,707

Thyroid Hormone Kinetics in Kidney Disease
12/1/84-11/30/88
$318,518

Modification of Diet in Renal Disease
1988-1993
$1,826,978

Parathyroid and uremia
NIH
$818,775

Coronary Artery Calcification
NIH
$ 367,419 (7/1/01-6/30/06)

J.    Clinical Trials:

Modification of Diet in Renal Disease
1988-1993 (Co-Investigator)

Use of  BioLogic-DT System in treatment of Drug Overdose,
1991-1994 (principal Investigator)

Multicenter Trial to compare efficacy of 125, Vitamin D3 plus 24, 24 Vitamin D in the treatment of osteitis fibrosa cystica maintained on chronic hemodialysis,
1990-1993 (Co-Investigator).

Multicenter Trial Morbidity and Mortality of Hemodialysis (MMHD)
(DOPPS) Dialysis Outcome Practice Pattern Study
1996-2000

IMS EPO Tracking Stud
Multicenter Trial,
1996

Open Label Study of the effects of Zemplar on patients with high bone turnover renal osteodystrophy  (Abbott Pharmaceuticals: $75000)
(10/2001) (Principal Investigator)

Correction of Hemoglobin and Outcomes in Renal Insufficiency
Ortho Biotech/ Care Stat
$ 112,500 for 3 years (Principal Investigator)

A Phase 111b, Multicenter, Two-Cohort, Randomized Study, with an Open-label Run-In and a Long-Term Extension Phase by Shire (continuing)
(Principal investigator)

FNH (Daily Hemodialysis)
NIH (Co-Investigator)

Treat study (By Amgen)
(Principal investigator) (continuing)

ASCEND (Speedel):  Study Terminated by Sponsors 2006

EPO-AKD-3001 (Johnson and Johnson)

ROCHE: (3 Studies)
Study:A Two-Arm Randomized open-Level Multicenter Study of safety and Efficacy of Monthly injections of RO0503821 versus Epoitin Alfa in Peritoneal Dialysis Patients who Self -inject or receive in-center injections.
Study B: Hemodialysis patients
Study C:  PreCKD patients

Shire: Extension study for hyperphosphatemia
(principal  Investigator)

Novo Nordisk Study (Principal investigator)

Affymax Study (Principal Investigator)

K.   National and International Scientific Conferences:

Invited Speaker:

1.  Calcium, Vitamin D and Parathyroid Hormone.  22nd Annual Scientific Symposium on Kidney Disease, Los Angeles, CA (Sponsored by NKFSC), 1982

2. 125 (OH)2 D and hypercalcemia in diuretic phase of acute renal failure due to rhabdomyolysis.  6th Vitamin D Workshop, Merano, Italy, 1985

3.  Rhabdomyolysis.  2nd International Bari Seminars in Nephrology, Bari, Italy, 1985

4. Diabetic Nephropathy.  6th International Conference on Health and Annual Convention of APPNA, Karachi, Pakistan, 1985

5.  Spectrum of Acute Renal Failure.  International Conference on Health, Peshawar, Pakistan, 1985

6.  Glucose Metabolism in Chronic Renal Failure.  25th Annual Scientific Symposium on Kidney Disease (Sponsored by NKFSC), 1985

7. Electrolyte Disturbances in Rhabdomyolysis in Rhabdomyolysis.  International Conference on “ Advances in Non-Invasive Nephrology”, Vienna, Austria, 1986

8.  Renal Disease in subacute bacterial endocarditis.  International Conference on Health, Peshawar, Pakistan, 1986

9. Medical Management of Nephrolithiasis.  International Conference on Health, Peshawar, Pakistan, 1986

10. Renal Metabolic Complications of antihypertensive agents.  International Conference on Health, Peshawar, Pakistan, 1987

11. Renal Disease associated with Mixed Connective Tissue Disease.  3rd Bari International Seminars in Nephrology, Bari, Italy, 1987

12. PTH and Carbohydrate Intolerance in Uremia.  New Actions of Parathyroid Hormone (International Conference), Kobe, Japan, 1987

13. PTH, Brain, Calcium and EEG.  New Actions of Parathyroid Hormone, Kobe, Japan, 1987

14. Renal Biopsy Workshop.  The surprises for renal biopsy.  18th Annual Scientific Meeting (NKF), Washington, 1988

15. The Adverse Effects of Excess PTH on Lipid Metabolism in chronic renal failure (CRF).  6th International Capri Conference on Uremia.  Pathophysiology of patients treated for 15-20 years, Capri, Italy, 1989

16. The Adverse Effects of Excess PTH on Lipid Metabolism in CRF.  International Symposium on calcium regulating hormone, body fluids, and kidney, Nara, Japan, 1990

17. Renal Calculi, Renal Disease, Causes, Effect and Management.  (Sponsored by CIGNA), Los Angeles Hilton, Los Angeles, CA, 1991

18.  Visiting Professor, Nassau County Medical Center, East Meadow, N. Y., 1990

19. Visiting Professor, Khyber Medical College, Peshawar, Pakistan, July 15-July 30, 1991

20. Hyperparathyroidism and Hyperlipidemia in CRF.  Conference Leo Ambard, Strasbourg, France, 1991

21. Diabetic Nephropathy and Management.  Los Angeles, CA.  (Sponsored by Indian Society of Medicine of North America)

22.  HIV and Hemodialysis.  Clinical Symposium (Sponsored by Clinishare), Los Angeles, CA, 1992

23. Diabetic Nephropathy and its Management.  14th Annual Winter Conference (Sponsored by Association of Pakistani Physicians of North America, 1993

24. Excess PTH and Right Ventricular Function.  Third International Conference on New Actions of Parathyroid Hormone.   Kyoto, Japan, 1994

25. Vascular Access: Problem and Treatment.  34th Annual Symposium on Kidney Disease.  LaJolla, CA.  1994

26. Left Ventricular Hypertrophy: ANNA.  Anaheim, CA.  1996

27. Dyslipidemia of ESRD.  36th Annual Scientific Symposium (Sponsored by NKFSC). Long Beach, CA.  1996.

28.  Pregnancy and Hypertension, International Scientific conference,
King Edward Medical College, Lahore, Pakistan, 1998

29.  Pregnancy and Renal failure, International Scientific Conference
Rawalpindi Medical College, Pakistan, 1998

30.  Preeclampsia, Pregnancy and Hypertension International Scientific Conference, Peshawar, Pakistan, 1998

31. Hemodialysis in diabetic patients. Second International Conference on Uremic Research, April, 2001,Nara, Japan

32. Dominick Gentile, MD Keynote Address, “Tissue Calcification”, 2001 Annual

33. Meeting & Education Conference, September, 14, 2001 at Palm Springs, CA.

34. Pre-end stage renal disease Kidney Month Lecture
General Family Practice
St. Vincent Medical Center, Los Angeles
March 21, 2002

35. 5th Annual Nephrology Symposium
Kaiser Permanente Continuing Medical Education
Cardiovascular Epidemic in Chronic Kidney Disease: Calcification of Arteries
The Queen Mary, Long beach, CA
May 3-4, 2002

36. International Symposium at Khyber Medical College, Peshawar, Pakistan, Dec. 2004. New Challenges and Strategies: Chronic Kidney Disease.

37. Hypertension in CKD at West Hill Hospital, CA, 2006

38. CKD, DM, and HTN: APPNA Annual Conference, Irvine, CA 2007

39. Drug Toxicity in Dialysis Patients, 2009
Mission Community Hospital, San Fernando Valley, CA

40.  Chronic Kidney Disease, 2009
Verdugo Hospital, Glendale, CA

41. Acute Renal Failure, 2009
Bellflower Medical Center, Bellflower, CA

42. Chronic Kidney Disease, 2009
Promise Hospital, Paramount, CA

L .  Chairperson Scientific Sessions:

1.  International Conference on Health.   Peshawar, Pakistan, 1985

2. 25th Annual Scientific Symposium on Kidney Disease.   Palm Springs, CA, 1985

3.  9th International Congress of Nephrology.   Los Angeles, CA, 1985

4. International Conference on “Advances in Non-Invasive Nephrology” Vienna, Austria, 1985

5.  27th Annual Scientific Symposium on Kidney Disease (National Kidney Foundation of Southern California).   LaJolla, CA, 1987

6. 28th Annual Scientific Symposium on Kidney Disease (National Kidney Foundation of Southern California).  Ventura, CA, 1988

7.  American Society of Nephrology. San Antonio, TX, 1988

8.   27th Annual Scientific Symposium on Kidney Disease (National Kidney Foundation of Southern California).  Palm Springs, CA, 1990

9.  Moderator of Symposium: Diabetes and its Sequele.  14th Annual Winter Conference of APPNA.  Peshawar, Pakistan, 1993

10. Nutrition:  The Neglected Aspects of Medical Treatment.  Peshawar, Pakistan, 1993

11. 3rd International Conference on New Actions of Parathyroid Hormone. Kyoto, Japan, 1994

12. 5th Annual Spring Clinical Nephrology Meeting of NKF.  A Creative Team Approach to optimize outcome with Renal Failure.  Anaheim, CA, 1996

13. 5th Annual Spring Clinical Nephrology Meeting of NKF.  Hands-On and Procedural Training Workshop:  Renal Ultrasonography and Percutaneous Renal Biopsy. Anaheim, CA, 1996

14. 5th International Annual Spring Clinical Nephrology Meeting of NKF.  Meet the Professor.  “Drug Induced Renal Function”.  Anaheim, CA, 1996

15. Hyperphosphatemia, Tissue Calcification and PTH in ESRD:  Cedar Sinai Med Center, Los Angeles, CA, October 12, 1999.

16. Anemia in Dialysis patients:  San Diego, CA, 2000

17. The effect of Zemplar on Excess PTH:  Community Lecture at Los Angeles, CA, 2000

18. PTH associated complications in CRF:  Community Lecture at Los Angeles, CA, 2000

19. Mini- Symposium on Kidney Diseases at Khyber medical college, Peshawar, Pakistan.

Reviewer:

1.  Mineral and Metabolism:  Since 1982

2.  American Journal of Nephrology:  Since 1981

3.  Kidney International: Since 1987

4.  American Journal of Kidney Disease: Since 1988

5.  Abstract Reviewer:  ( American Society of Nephrology)

M.        Advisory Consultant:

Total Renal Care
Physician Advisory Board Meeting
Las Vegas, Nevada, 1997

Total Renal Care
Physician Advisory Board Meeting
Las Vegas, Nevada, 1998

Total Renal Care
Physician Advisory Board Meeting
Las Vegas, Nevada
November, 20, 1999

DCA Research Foundation, Physician Advisory Meeting
Symposium on “integrating informatics and Telemedicine to improve Clinical Outcomes” Las Vegas, Nevada
February 4-7, 1999

Ferrilecit Consultant Meeting
Marina del Rey, CA, July 22, 2000

Genzyme
Renagel Capsules
Consultant Feedback Meeting
Washington, DC

Baxter
New Orleans

Renal Advisory Meeting
Abbott Renal Care
Vail, CO,
January 23-24, 2000

Baxter
Care Advocacy Development and Speaker Training Meeting at Aventura, Florid,
October 28-29, 2000

Bibliography:

Publications:

1. Akmal, M. and Manzler, A.D.:  Simplified assessment of pituitary-adrenal axis in a stable group of hemodialysis patients.  Trans. Am. Soc. of Intern. And Org.  XXXIII: 703-707, 1977.

1. Akmal, M.; Goldstein, D.A.; Telfer, N.; Wilkinson, E. and Massry, S.G.:  Resolution of muscle calcification in rhabdomyolysis and acute renal failure.  Ann. Int. Med. 89: 928-930,1978.

1. Massry, S.G.; Goldstein, D.A. and Akmal, M.:  Parathyroid hormone and the uremic syndrome.  Contro. Nephrol, Vol. 1, 1978.

1. Feinstein, E.I.; Akmal, M.; Goldstein, D.A.; Telfer, N. and Massry, S.G.:  Hypercalcemia and acute widespread calcification during the oliguria phase of acute renal; failure due to rhabdomyolysis.  Min. Elect. Metab., 89:928-930, 1979.

1. Haldimann, B.; Goldstein, D.A.; Akmal, M.; and Massry, S.G.:  Renal Function and blood levels of divalent ions in acute pancreatitis.  A prospective study in 99 patients.  Min. Elect. Metab., 3:190-199, 1980.

1. Feinstein, E.I.; Akmal, M.; Telfer, N. and Massry, S.G.:  Delayed hypercalcemia in patients with acute renal failure associated with non-traumatic rhabdomyolyis.  Arch. Int. Med., 141:753-755, 1981.

1. Akmal, M.; Valdin, J.; McCarron, M.D. and Massry, S.G.:  Rhabdomyolysis with and without acute renal failure in patients with phencyclidine intoxication.  Am. J. Nephrol., 1:91-96, 1981.

1. Akmal, M.:  Clinical  aspects of renal disease associated with mixed connective tissue disease, in Glassock, Goldstein.  Recurrent acute renal in a patient with mixed connective tissue disease.  Am. J. Nephrol., 2:282-290, 1982.

1. Glassock, R.J.; Goldstein, D.A.; Akmal, M.; Boswell, W.D. and Eknoyan, G.:  Hematuria in a 42 year old woman.  Am. J. Nephrol., 2:233-244, 1982.

1. Glassock, RJ, Goldstein, DA, Akmal, M, Kitridou, R and Koss, M.:   Recurrent acute renal failure in a patient with mixed connective tissue disease.  2(5)287-290, 1982.

1. Massry, S.G.; Frohling, P.T. and Akmal, M.:  Is parathyroid hormone involved in progression of renal failure (Prevention of Progressive Uremia). Vol. 1:125-127, 1982.

1. Malluche, H.H.; Akmal, M.; Meir, E.; Norman, A. and Massry, S.G.:  Parathyroid hormone reverses effects of 125 (OH)2 vitamin D on bone dynamics.  Vitamin D, chemical, biochemical and clinical endocrinology of calcium metabolism proceedings of the fifth workshop on vitamin D, Williamsburg, VA, USA, Editors: A. W. Norman, K. Schaeffer, D.V. Herrath, and H.G. Grigoleit.  539-544, 1982.1.

1. Akmal, M. and Massry, S.G.:  Nerve damage associated with rhabdomyolysis.  Arch. Intern. Med., 143:835-837, 1983.

1. Massry, S.G. and Akmal, M.: Metabolic and endocrine abnormalities after renal transplantation. Textbook of Nephrology, Eds. Shaul G. Massy and Richard  J. Glassoc 1^st. Edition, Chapter 74, Part 3,pp.9.34-9.36, 1983.

1. Akmal, M.; Kidridou, R.; and Massry, S.G.:  Mixed connective tissue disease.  Textbook of Nephrology, eds. Shaul G. Massry and Richard J. Glassock.  Ist Edition, Chapter 42, Part2, pp. 6.94-6.96, 1983.

1. Massry, S.G.; and Akmal, M.:  Heroin associated nephropathy.  Textbook of Nephrology, eds. Shaul G. Massry and Richard J.  Glassock.  Ist Edition, Chapter 43, Part 4, pp. 6.202-6.204.

1. Blau, R.H.; Akmal, M.; Koss, M. and Quismorio, F.:  Palpable leg purpura and renal failure in a 23 year old man.  Western J. Med. 140:60-65, 1984.

1. Akmal, M.; Goldstein, D.A.; Multani, S. and Massry, S.G.:  Role of uremia, brain CA and parathyroid hormone on changes in  electroencephalogram in   chronic renal failure.  Am. J.Physiol., 245:F575-F579,1984.

1. Akmal, M.; Tuma, S.; Goldstein, D.A.; Pattabhiraman, R.; Bernstein, L. and Massry, S.G.: Intact and carboxyterminal PTH do not cross the blood-cerebrospinal fluid barrier. Proceedings for Experimental Biology and Medicine, 1976:434­437, 1984.

1. Akmal, M.; Massry, S.G.; Goldstein, D.; Fanti, P.; Weisz, A.  and DeFranzo, R.A.: Role of parathyroid hormone in the glucose  intolerance in uremia.  J. Clin. Invest., 75:1037-1044, 1985.

1. Akmal, M.; Telfer, N.; Ansari, A. and Massry,  S.G.:  Erythrocyte survival in chronic renal failure:  Role of  secondary hyperparathyroidism. J. Clin. Invest., 76:1695-1698, 1985.

1. Akmal, M.:  Electrolytes disturbances in patients with rhabdomyolysis.  Advances in non-invasive Nephrology, by Gert Lubec and Vito Campese, pp. 120- 122, 1985.

1. Akmal, M.; Kaptein, E.M.; Bertram, J. and Massry, S.G.: Acute renal failure due to bilateral ureteral obstruction by metastases from breast cancer.  Nephron., 42:23-28, 1986.

1. Akmal, M.; Bishop, J.E.; Telfer, N.; Norman, A.W. and Massry, S.G.: Hypocalcemia and hypercalcemia in patients with rhabdomyolysis with and without acute renal failure. J. Clin. Endocrinol Metab., 63:137-142, 1986.

1. Kitridou, R.C.; Akmal, M.; Turkel, S.; Ehresmann, S.G.; Quismorio, F.P. and Massry, S.G.: Renal involvement in mixed connective tissue disease.  A longitudinal clinico-pathological study.  Seminars Arth. Rheumat., 16:135-145,1986.

1. Massry, S.G. and Akmal, M.: Osmotic fragility of red blood cells, secondary hyperparathyroidism, and uremia.  Nephron., 43:70-71, 1986.

1. Akmal, M.: In Feinstein, Nephrotic syndrome in a woman with diabetes mellitus and rheumatoid arthritis. Am. J. Nephrol., 7:77-83, 1987.

1. Akmal, M; Goldstein, D.A.; Kletzky, O.A. and Massry, S.G.: Hyperparathyroidism and hypotestosteronemia of acute renal failure.  Am. J. Nephrol., 8:166-169, 1988.

1. Fadda, G.Z.; Akmal, M.; Primdas, F.H.; Lipson, S.G. and Massry, S.G.: Insulin release from pancreatic islets: Effects of CRF and excess PTH.  Kid. Int., 33:1066-1072, 1988.

1. Soliman, A.R.; Akmal, M. and Massry, S.G.:  Parathyroid hormone interferes with extrarenal disposition of potassium in chronic renal failure.  Nephron, 52:262-267, 1989.

1. Fadda, S.Z.; Akmal, M.; Soliman, A. and Massry, S.G.:  Correction of glucose intolerance and the impaired insulin release of chronic renal failure by verapamil.  Kidney Int., 36:773-779, 1989.

1. Massry, S.G.; and Akmal, M.: Lipid abnormalities, renal failure and parathyroid hormone. Am. J. Med., 87:5-42N, 1989.

1. Kaptein, E.M.; Hoopes, M.T.; Pattabhiraman, R; Akmal, M. and Massry, S.G.: Separation of iodothyronines from iodinated metabolites in serum from reverse T3 tracer kinetic  studies in man and dog: A comparison of two metals.  Horm. Metabol. Res., 21:678-681, 1989.

1. Akmal, M.: Rhabdomyolysis Associated Acute Renal Failure.  IM Internal Medicine for the Specialist.  IM/10:118-124, 1989.

1. Massry, S.G.; Fadda, G.Z.; Akmal, M.: Carbohydrate intolerance and impaired pancreatic insulin release in chronic renal failure: Role of excess blood levels of parathyroid hormones.  pp. 219-245, 1989.  In: New actions of parathyroid hormone.  Edited by Shaul G. Massry and Takuo Fujita.

1. Akmal, M. and Massry, S.G: Metabolic and endocrine abnormalities after renal transplantation.  Textbook of Nephrology, eds. Shaul G. Massry and Richard J. Glassock.  2^nd Edition, 1989.

1. Akmal, M. and Shaul G. Massry.:  Mixed connective tissue disease.  Textbook of Nephrology, eds. Shaul G. Massry and Richard J. Glassock, 2^nd. Edition, pp. 703-705, 1989.

1. Massry, S.G. and Akmal, M.:  Heroin associated nephropathy.  Textbook of Nephrology, eds.  Shaul G. Massry and Richard J. Glassock, 2^nd. Edition, pp. 848-851, 1989.

1. Akmal, M.: Renal disease associated with Mixed Connective Tissue.  Advances in Experimental Medicine and Biology, 252:53-58, 1989.

1. Akmal, M.; Kasim, S.E.; Soliman, A.R.; Massry, S.G.: Excess parathyroid hormone adversely affects lipid metabolism in chronic renal failure.  Kidney Int., 37:854-858, 1990.

1. Akmal, M.; and Massry, S.G.; Reversible hepatic dysfunction associated with rhabdomyolysis.  Am. J. Nephrol., 10:49-52, 1990.

1. Kaptein, E.M.; Hoopes, M.R.; Ferguson, D.C.; Satyadi,  E.C.; Akmal, M.: Comparison of reverse triiodothyronine distribution and metabolism in normal dogs and humans.  Endocrinology 126: 2003-2014, 1990.

1. Fadda, G.; Akmal, M.; Lipson, L. and Massry, S.G.: Direct effect of excess PTH on insulin secretion from pancreatic islets.  Am. J. Physiology 258: (Endocrinol-Metab.  21:E975­E984, 1990).

1. Akmal, M. and Massry, S.G.: Decreased motor nerves conduction, chronic renal failure and excess PTH. Proceedings for experimental biology and medicine.  195:202-207, 1990.

1. Akmal, M.: and Om P. Sharma: Renal Sarcoidosis; A Reminder (Editorial).  Chest 97:1284-1285, 1990.

1. El-Shahawy, M.A.; Gadallah, M.F.; Teitelbaum, G.P.; Kaptein, E. and Akmal, M.,:  Compression of the left brachiocephalic vein by the innominate artery resulting in massive arm edema in a hemodialysis patient. Am.J.Nephrol., 12:108-110, 1992.

1. Akmal, M.: Rhabdomyolysis in a patient with hypocalcemia due to hypoparathyroidism.  Am J Nephrology., 13:61-63,1993.

1. Akmal, M.; Perkins, S., Kasim, S.; Oh, H., Smogorzewski, M., Massry, S.G: Verapamil prevents CRF-induced abnormalities in lipid metabolism. Am. J. Kidney Dis., 22(1):158­163,1993.

1. Macho, R; Ameriso, S.; Akmal, M.: Mohler, J.; Massry, S.G.; Meiselman, H.; Fisher, M.: Hemorrheological factors, oxygenation and age correlates of middle cerebral artery velocity.  Stroke.  24:1025-1028, 1993.

1. El-Shahawy, M.; Francis, R.; Akmal, M. and Massry, S.G.:  Recombinant human erythropoietin shortens bleeding time (BT) and corrects abnormal platelets aggregation   (PA) in hemodialysis  patients (HDP).  Clinical Nephrology.  41(5): 308-313, 1994.

1. Akmal, M.; Sawelson, S.; Karubian, F. and Gadallah, M.: The prevalence of occult blood loss in patients with predialysis advanced chronic renal failure (CRF), or receiving dialytic therapy.  Clinical Nephrology.  42:198-202, 1994.

1. Liou, H.H.; Shooh-Shan, C.; Shi-Ching, T.; Ching, Chun, C.; Shih-Chun, W.; Tung-Po, H.; Akmal, M.: Intravenous or Oral Calcitriol Treatment in Chronic Hemodialysis Patients with Secondary Hyperparathyroidism: Comparative Study.  Min. Elec. Metab., 20:97-102, 1994.

1. Akmal, M.; Massry, S.G.: Renal complications associated with Heroin. In: Textbook of Nephrology,  3^rd Edition, eds, S.G. Massry, R.. Glassock (Williams        and Wilkins CO) 3^rd. Edition, Part 6, pp. 970-974, 1994.

1. Akmal, M.; Barndt, R., Ansari, A. and Massry, S.G.: Right ventricular Hypertrophy  (RVH) and Pressure (RVP) mean Pulmonary Artery Pressure (MPA) and Lung Calcification in CRF.  Kidney Intern.  47:158-163,1995.

1. Alexiewicz, J. M; Smogorzewski, M; Klin, M; Akmal, M; Massry, S.G.: Effect of Treatment of hemodialysis patients (HD) with Nifedipine on metabolism and function of  polymor­phonuclear  leucocytes  (PMNL).  Am J Kidney Dis. 25(3): 440-444, 1995.

1. Akmal, M.; Bughi, S.; and Kaptein, E.M.:  Endocrine dysfunction in Chronic renal failure.  In: Clinical dialysis, 3^rd.Edition, Nissenson A, Fine RN, and Gentile D, Appleton and Lange, pp. 714-743, 1995.

1. Alexiewicz, J. M; Smogorzewski, M; Akmal, M; Klin, M; Massry, S.G:  Nifedipine reverses the abnormalities in [CA2]i and proliferation of B-Cells from dialysis patients.  Kidney Intern. 50:1249-1254, 1996.

1. Alexiewicz, M.; Smogorzewski, M.; Gill, S.K.; Akmal, M.; Massry, S.G.:  Time Course of the Effect of Nifedipine Therapy and its Discontinuation on [CA²⁺]_i and Phagocytosis of Polymorphonuclear Leukocytes from Hemodialysis Patients.  Am. J. Nephrol., 17:12-16, 1997.

1. Alexiewicz, M; Smogorzewski, M; Akmal, M; Massry, S.G: A longitudinal-study on the effect of Nifedipine Therapy and its discontinuation on [CA2]i and proliferation of B-Lymphocytes of dialysis patients.  Am J Kidney Dis. 29(2):233-238, 1997.

1. Akmal, M..: Disfuncion endocrina en la Insuficiencia Renal Conica y Alteraciones de los carbohidratos y lipidos. Capitulo 21: pp 559-637, 1997.  Insuficiencia Renal Cronica, Dialysis y Transplante Renal by Llach and Valderrabano(2nd Edition).

1. Ziouzenkova, O; Asatryan, L; Akmal, M; Tetta, C; Wratten, M.L; Loseto-Wich, G; and Sevanian, A:  Oxidative Cross-linking of Apo B100 and Hemoglobin Results in Low Density Lipoprotein Modification in Blood: Relevance to Atherogenesis Caused by Hemodialysis. J Biol Chem.  2; 274(27): 18916—24.

1. 62. Kaptein, EM; Levenson, H; Siegel,  ME;  Gadallah, M; Akmal, M: Radioiodine             dosimetry in patients with end-stage renal disease continuous ambulatory peritoneal dialysis therapy.

1. Akmal, M, S.G.Massry: Heroin associated nephropathy.  Textbook of Nephrology, eds. Shaul G Massry and Richard J. Glassock.  3rd Edition (2001).

1. Akmal, M: Hemodialysis in Diabetic Patients.  AJKD, 33(4)Suppl 1, S195- S199, 2001

1. Ash, SR;  Levy, H;  Akmal, M;  Mankus, RA;  Sutton, JM;  Emery, DR;  Scanl, JC; Blake, DE; Carr, DJ:  Traetment of severe tricyclic antidepressant overdose with extracorporeal sorbent detoxification.  ADV REN Replace Ther. 9(1): 31-41, 2002.

Manuscripts in Preparation:

Akmal, M65. Akmal, M.; Koss, M. et al.: The spectrum of postpartum renal disease.

1. Akmal, M.; et al.: Histologic diabetic renal lesions in the absence of chemical diabetes.

1. Akmal, M and Sharma, O.: Bone tuberculosis in a patient on steroid therapy for sarcoidosis.

1. Akmal, M. et al: Cardio-pulmonary calcification in chronic renal failure.

1. Rhabdomyolysis:  Long term Expeiance.

1. Silent Diabetic nephropathy.

1. Pregnancy in Dilaysis patients.

1. Tissue calcification in CKD:  The Effect of  Excess PTH.

1. Inceasse in CPK Isoenzymes in Dialysis patients.

1. Kidney Disease in Leprosy

Abstracts:

1. Akmal, M. and Manzler, A.D.; Simplified assessment of pituitary-adrenal axis in a stable group of chronic hemodialysis patients. A.S.A.I.O. XXXIII.  Presented in Montreal, 1977.

1. Akmal, M.; Goldstein, D.; Telfer, N.; Wilkinson, E. and Massry, S.G.: Muscle clarifications in acute renal failure due to rhabdomyolysis and their resolution after recovery of renal function.  Kid. Int. 14-644, 1978.  Presented at 11^th.  Annual Meeting of American Society of Nephrology, in New Orleans, Louisiana, 1978.

1. Kitridou, R.C.; Akmal, M.; Ehresman, G.R.; Quismorio, F.P. and Massry, S.G.:  Nephropathy in mixed connective tissue disease. Arthr.Rheum22: 704, 1980. Presented at the American Rheumatism Association in 1980.

1. Akmal, M.; Goldstein, D.A.; Multani, S. and Massry, S.G.:     Parathyroid hormone and glucose intolerance in uremia.  Kid.      Int. 19:194, 1981.  Presented at the 13^th Annual Meeting of American Society of Nephrology in 1980, in Washington, D.C.

1. Melluche, H.H.; Akmal, M.; Goldstein, D.A. and Massry, S.G.:  Role of parathyroid hormone in renal osteodystrophy.  Presented at the 8^th. International Congress of Nephrology, Athens, Greece in 1981.

1. Melluche, H.H.; Akmal, M.; Goldstein, D.A.; Meir, E.; Norman, A.W. and Massry, S.G.: The role of lack of hormone  (PTH) in the pathogenesis of uremic low turnover osteodystrophy Kid. Int. Vol. 21, No. 1, 1982.  Presented at 14^th. Annual meeting of the American Society of Nephrology, in 1981, in Washington, D.C.

1. Akmal, M.; Telfer, N. and Massry, S.G.:  Hypocalcemia and calcium deposition in soft tissues with acute renal failure without rhabdomyolysis and in those with rhabdomyolysis with and without acute renal failure.  Kid. Int., Vol. 21, No. 1, 1982.  Presented at the 14^th Annual Meeting of the American Society of Nephrology, in 1981, in Washington, D.C.

1. Melluche, H.H.; Akmal, M.; Meir, E.; Norman, A.W. and Massry, S.G.:  Parathyroid hormone is needed for the positive effect of 1, 25 (OH) 2 vitamin D on bone formation and mineralization.  Bone and Mineral Research, 1982.  Presented at the American Society  for  Bone and  Mineral Research, in 1982, at San Francisco, CA.

1. Telfer, N.; Akmal, M. and Massry, S.G.: Technetium 99-methyl diphosphonate (DMP) soft tissue uptake in acute renal failure (ARF) with and without rhabdomyolysis (RBD) and in RBD without renal failure.  J. Nuclear Med. Vol.  23, No. 5, 1982.  Presented at the Annual Meeting of American Society of Nuclear Medicine, in 1982, at Miami Beach, FL.

1. Malluche, H.H.; Akmal, M.; Meir, E.; Norman, A.W. and Massry, S.G.:  125 (OH) vitamin D increases bone formation and mineralization in uremic dogs.  An effect dependent upon presence of parathyroid hormone.  AFC   Midwest 1982.

1. Akmal, M.; Goldstein, D.A.; Multani, S. and Massry, S.G.: Role of uremia, increased brain calcium (Ca) and parathyroid hormone on changes in electroencephalogram (EEG) in chronic renal failure Kid.Int., Vol.23, No.1, 210,1983. Presented at the 1 5^th Annual Meeting of the American Society of Nephrology in 1982, at Chicago, IL.

1. Akmal, M.; Goldstein, D.A.; Tuma, S.; Fanti, P.; Pattabhiraman,  R. and Massry, S.G.:  The effect of PTH on blood brain barrier.  Clin. Research, Vol. 31, No. 1,  52A.

1. Akmal, M.; Massry, S.G. and DeFronzo, R.: Role of parathyroid­ hormone in insulin secretion and glucose metabolism in chronic renal failure.  Kid. Int. Vol. 25:24,  1984.   Pre­sented at the 16^th Annual Meeting of the American Society of Nephrology in 1983, Washington, and D.C.

1. Akmal, M.; Norman, A.W.; Bishop, J. and Massry, S.G.:  125 (OH)2 D3 and hypercalcemia in diuretic phase of acute renal failure  due to rhabdomyolysis.  Page 443, Sixth Vitamin D Workshop, Merano, Italy, 1985.  Presented at Merano, Italy, in 1985.

1. Akmal, M.; Norman, A.W.; Bishop, J. and Massry, S.G.:  125 (OH) 2 D and Hypercalcemia in diuretic phase of acute renal failure due to rhabdomyolysis.  Kid. Int., 27:226, 1985.

1. Fadda, G.Z.; Akmal, M.; Primdas, F.; Lipson, L. and Massry, S.G.: Direct evidence for an inhibitory effect of parathyroid hormone (PTH) on insulin release in chronic renal failure (CRF).  Kid. Int., 31:384, 1987.  Presented at the 19^th.Annual Meeting of the American Society of  Nephrology, in 1986, in Washington, D.C.

1. Ansari,  A.N.; Hung, G.L; Siegel, M.E.;  Lundell, C. and Akmal, M.:  The detection of renal artery stenosis with captopril renography in patients on antihypertensive therapy.  Nuclear Medicine, 1987.  Presented at the Annual Meeting of American Society of Nuclear Medicine.

1. Fadda, G.Z.; Akmal, M.; Lipson, L. and Massry, S.G.: Evidence for correction of glucose intolerance and insulin secretion by verapamil in chronic renal failure.   Presented at the American College of Physicians Meeting in 1988, at San Diego, CA.

1. Fadda, G.Z.; Akmal, M.; Soliman, A.R.; Lipson, L.G. and Massry, S.G.:  Correction of glucose intolerance (GINT) and the impaired insulin release of chronic renal failure (CRF) by verapamil.  Kidney Int. 35:427, 1989.  Presented at the 21^st. Annual Meeting of the American Society of Nephrology, in 1988, at San Antonio, Texas.

1. Akmal, M.; Kasim, S.E.; Soliman, A.R. and Massry, S.G.:  Excess parathyroid hormone adversely affects lipid metabolism in chronic renal failure (CRF).  Kidney Int. 35:422, 1989.  Presented at the 21^st. Annual Meeting of the American Society of Nephrology, in 1988, at San Antonio, TX.

1. Akmal, M.; Kasim, S.E.; Soliman, A.R. and Massry, S.G.:  The adverse effects of excess parathyroid hormone (PTH) on lipid metabolism in chronic renal failure (CRF). Sixth International Capri Conference on Uremia.  (Pathophysiology of patients treated for 15-20 years, Capri Island, Italy, September 1989 (Page 1).

1. Akmal, M., and Massry, S.G.: Reversible hepatic dysfunction. Nephrology in 1989, at Washington, D.C.

1. Fadda, G.Z.; Akmal, M.; Lipson, L. and Massry, S.G.: Evidence for a direct effect of parathyroid hormone on pancreatic islets.  Kidney Int. 37:466, 1990.  Presented at the 22^nd.  Annual Meeting of the American Society of Nephrology in      1989, at Washington, D.C.

1. Sawelson, S.; Akmal, M.; Gadallah, M; Karubian, F. and Massry, S.G.:  Incidence and cause of  gastrointestinal bleeding  in uremic, hemodialysis (HD) and chronic ambulatory peritoneal dialysis patients.  Kidney Int., 37:244, 1990.

1. Akmal, M.; Kasim, S.E.; Soliman, A.R. and Massry, S.G.: The adverse effects of excess-parathyroid hormone on lipid metabolism in chronic renal failure. International symposium on calcium regulating hormones, body fluids and kidney.  Abstract 37, 1990, NARA, JAPAN.  Presented in July 1990, at NARA, JAPAN.

1. Akmal, M.; Barndt, R.; Ansari, A. and Massry, S.G.: Right      pulmonary artery pressure (MAP) and lung calcification in chronic renal failure (CRF).  JACN, Page 583, 1990.

1. Kaptein, E.; Levenson, H. and Akmal, M: Determination of radioiodine dose for papillary thyroid carcinoma (CA) in 68.p 90.  Presented at the 23^rd. Annual Meeting of the American Society of Nephrology, in 1990, at Washington, D.C.

1. El-Shahawy, M.; Francis, R.; Akmal, M.; Massry, S.G.: Recombinant human erythropoietin shortens bleeding time (BT), and corrects abnormal platelet aggregation (PA) in hemodialysis patients (HDP).  JACN 42 p.90. Presented at 23^rd. Annual Meeting of the American Society of Nephrology, in 1990, at Washington DC.

1. Macko, R.; Ameriso, S.F.; Akmal, M.; cerebral artery velocity.  Neurology, G40p, 91. Presented at the Academy of Neurology,  43^rd Annual Meeting  Program,  April 1991, at Boston, MA.

1. Levenson, H.l; Akmal, M.; Siegel, M.E. and Kaptein, E.M.: Radioiodine dosage for papillary thyroid carcinoma in chronic ambulatory peritoneal dialysis (CAPD).  Nuclear Medicine, 1991.  Presented at the Annual Meeting of Nuclear Medicine in June 1991, at Cincinnati, OH.

1. Macko, R.; Aeriso, S.F.; Akmal, M.; Mohler, J.; Massry, S.G.; Meiselman, H.J.; Fisher, M.: Arterial oxygen content is a fundamental determinant of middle cerebral artery blood flow velocity.  Presented at the 17^th International Joint Conference on Stroke and Cerebral Circulation, Phoenix, AZ. 1992.

1. Kaptein, E.; Levenson, H.;  Siegel, M.E.; Akmal, M.:  End-stage renal disease patients  (ESRD) receiving chronic ambulatory peritoneal dialysis (CAPD) require reduced radioiodide dosage for thyroid carcinoma. Accepted for presentation at ATA, Rochchester, MN, September 1992.

1. Akmal, M; Perkins, S.; Massry, S.G.:  Parathyroidectomy and treatment with verapamil prevents tissue calcification in CRF.  Presented at ASN, 1992.

1. El-Shahawy, M.; Francis, R.; Akmal, M.; Massry, S.G.: Recombinant Human Erythropoietin (r-HuPo) shortens bleeding time and correctly the abnormal aggregation in hemodialysis patients.  Presented at 2^nd Clinical Nephrology Meeting, Chicago (April 22-25, 1993) Clinical Nephrology Meetings of NFK.

1. Katz, M.D.; Difiori, J.L.; Kaptein, E.M.; Akmal, M.; Harrell, D.S.; Hanks, S.E.: Prolonging patency with endovascular stents for venous stenoses in dialysis grafts.  79^th. Scientific Assembly and Annual Meeting of the Radiological Society of North America, Chicago (Nov. 28-Dec. 3, 1993).

1. Kaptein, E.M.; Katz, M. D.; Hanks, S.E.; Akmal, M.: Endovascular stents for venous stenosis prolong the patency of hemodialysis patients. JASN p. 358, 1993.  Presented at the American Society of Nephrology, 26^th Annual Meeting at Boston. (Nov. 14-17) 1993.

1. Akmal, M; Hanks, S.E.; Katz, M.D.; Kaptein, E.M.: Limb edema as a complication of venous catheterization and arteriovenous (AV) access creation for hemodialysis.  JASN, p.330, 1993. Presented at the American Society of Nephrology, 26^th Annual Meeting at Boston. (Nov.14-17), 1993.

1. Liou, H.H.; Shooh-Shan, C.; Shi-Ching, T.; Ching-Chun, C.; Shih-Chun, W.; Tung-Po, H.; Akmal, M.:  Intravenous or Oral Calcitriol Treatment in Chronic Hemodialysis Patients with Secondary Hyperparathyroidism: Comparative Study. JASN, p. 723, 1993,  Boston. (Nov. 14-17) 1993.

1. Akmal, M.; Massry, S.G.:  Right ventricular Hypertrophy (RVH) and Pressure (RVP), Mean Pulmonary Artery.  Pressure (MPAP), Diffusion Capacity of Lungs (DLCO) and Lung Calcification in Chronic renal failure (CRF).  Presented at Third International Conference on New Actions of Parathyroid Hormone. At Kyoto, Japan, April 18-21, 1994.

1. Liou H.H.; Lin K.P.; Tarng D.C.; Huang T.P.; Akmal, M:  Effect of intravenous calcitriol on peripheral nerve conduction velocity in hemodialysis patients. Presented at Third International Conference on new actions of Parathyroid Hormone. At Kyoto, Japan, April 18-21, 1994.

1. Lieu, H.H.; Lin K.P.; Akmal, M.:  Effects of excess parathyroid hormone and intravenous 125, (OH) 2D3 (IVC) therapy on peripheral nerve conduction velocity (NCV) in HD patients JASN. 5(3):884, 1994.

1. Alexiewcz, M.; Smogorzewski, M.; Klin, M.; Akmal, M.; Massry, S.G.:  Effect of Treatment of hemodialysis patients (HD) with Nifedipine on metabolism and function of polymorphonuclear leucocytes PMNL). JASN. 5:323, 1994. Presented at 27^th Annual Meeting of American Society of Nephrology at Orlando, Florida, in Oct 1994.

1. Akmal, M.; Tak T.; Kaptein E.M.:  Left Ventricular Hypertrophy (LVH) in HD patients   with normal serum cholesterol(CH) and triglycerides (TG).  JASN. 5:487, 1994.

1. Alexiewicz, J.M; Smogorzewski, M; Klin, M; Akmal, M; Massry, S.G:  Effect of treatment of hemodialysis (HD) patients with nifedipine on metabolism and function of B-Cells.  JASN. 6(3)572, 1995.

1. Akmal, M.; Tak T.; Kaptein E.M.:  Left Ventricular Hypertrophy (LVH) in HD Patients with normal serum cholesterol (CH) and triglycerides (TG).  ISN, 1995.

1. Akmal, M.; Kaptein E.M.:  Successful use of erythrpoietin (EPO) and intravenous iron therapy in pregnant HD patients.  Poster Presented at 5^th Annual Spring Clinical Nephrology Meetings of the NKF, April 22-26, 1996, Anaheim, CA. AJKD. 27:A1, 1996.

1. Akmal, M.; Koss M.; Rea, T.E.:  Renal lesions in treated leprosy patients.  Poster Presentation at 5^th Annual Spring Clinical Nephrology Meetings of the NKF, April 22-26, 1996, Anaheim, CA. AJKD. 27: A1, 1996.

1. Akmal, M.; Azizullah Ansari, Massry, S.G.: Calcification in end-stage renal failure (ESRD), and the effect of excess parathyroid hoemomne (PTH).  Poster  Presentation  at 5^th Annual Spring Clinical Nephrology Meetings of the NKF, April 22-26, 1996, Anaheim, CA.  AJKD: 27: A1, 1996.

1. Alexiewicz, J.M.; Smogorzewski, M.; Gill, S.; Akmal, M.; Massry, S.G.: The course of effect of Nifedipine therapy and it’s discontinuation on [Ca²⁺]i and phagocytosis (PHAG) ofPMNL from hemodialysis patients.  Oral Presentation at 5^th Annual Spring Clinical Nephrology Meetings of the NKF, April 22-26, 1996. Anaheim, CA. AJKD. 27:A1, 1996.

1. Weisman, M.L; Tak, T; Akmal, M:  CK-MB activity in End-Stage renal disease.  JASN. 7(9):A0401, 1996.

1. Akmal, M; Yassa, N; Kaptein, E.M:  Left Ventricular Hypertrophy and Carotid Artery lesions in HD patients.  JASN. 7(9): A0943, 1996.

1. Alexiewicz, J. M; Smogorzewski, M; Gill, S; Akmal, M; Massry,S.G:  Time course of the effect of Nifedipine therapy and its discontinuation on [CA2]i and proliferation of B Cells from HD patients.  JASN.  7(9): A0337, 1996.

1. Ziouzenkova O; Asatryan, L; Akmal, M; Wratten M,L; Tetta, C; Sevanian, A:  Novel Hemodialysis Procedure utilizing antioxidants decreases oxidative stress during EX-VIVO Circulation of blood. Presented at the American Society of Nephrology, at Philadelphia, 1998.  Kidney Int. S 330, 1998.

1. Ash, SR; Levy, H; Akmal, M; Mankus,  RA; Sutton, JM; Emery,  DR; Scanlon,  JC; Blake, DE; Carr DJ: Treatment of severe Tricyclic antidepressant overdose with BioLogic-DT System.  Presented at the American Society of  Nephrology,  Miami, FL, 1999(Abstract # SA748)

1. Hemodialysis in diabetic patients. Presentation in April 2000 at Second International Conference on Uremic Research, Nara, Japan.

1. Chronic Kidney Disease: Presentation in December, 2004 at Khyber Medical College, Peshawar, Pakistan. Pathophysiology, New realities and Strategies. International Scientific symposia arranged by Pakistani Physicians of North America.